DCIS is cancer, but it behaves differently from invasive breast cancer

DCIS stands for ductal carcinoma in situ. It is cancer — the cells are abnormal and grow where they should not. But DCIS is confined to the milk ducts of the breast and has not broken through into surrounding tissue. This distinction matters enormously for how doctors treat it and what it means for your future.

The word "in situ" means "in place." The cancer cells are still contained within the duct. They have not invaded the fatty tissue around the duct, the lymph nodes, or anywhere else in the body. Because of this, DCIS is sometimes called stage 0 breast cancer — it is the earliest form.

Many people newly diagnosed with DCIS feel confused about whether they truly have cancer. The answer is yes, but the prognosis and treatment options are quite different from invasive breast cancer, which is why understanding the distinction matters.

Key Takeaways

  • DCIS is cancer confined to the milk ducts and has not spread into surrounding breast tissue or beyond.
  • Because DCIS has not invaded surrounding tissue, it is classified as stage 0 breast cancer, the earliest stage.
  • The main concern with DCIS is that it may develop into invasive breast cancer in the future, though not all DCIS will progress.
  • Treatment options include surgery alone, surgery with radiation, or in some cases surgery with hormone therapy, depending on the size and characteristics of the DCIS.
  • After treatment, regular mammograms and clinical breast exams are used to watch for recurrence or new cancer development.

How DCIS differs from invasive breast cancer

Invasive breast cancer has broken through the duct wall and entered the surrounding tissue. From there, it can spread to lymph nodes and other parts of the body. DCIS has not crossed that boundary. The cancer cells remain inside the duct, which is why it cannot spread to distant organs at the time of diagnosis.

This difference changes the treatment approach significantly. With invasive cancer, doctors often recommend chemotherapy to target cells that may have already traveled elsewhere. With DCIS, chemotherapy is rarely used because the cancer has not left the duct. Surgery is usually the main treatment.

The survival outlook is also different. People diagnosed with DCIS have an excellent prognosis. The 10-year survival rate is very high — most sources report rates above 95 percent. The main risk is not death from DCIS itself, but the possibility that DCIS will later develop into invasive cancer in the same breast or the other breast.

Why DCIS is still considered cancer

Some people question whether DCIS truly qualifies as cancer because it has not invaded surrounding tissue. The answer lies in what the cells look like under a microscope. In DCIS, the cells show the hallmarks of cancer: they are abnormal, they grow rapidly, and they do not follow the normal rules that control cell behavior.

If DCIS is left untreated, there is a real risk that over time the cells will break through the duct wall and become invasive cancer. Studies show that without treatment, roughly 20 to 30 percent of people with DCIS will develop invasive breast cancer within 10 years. This is why doctors treat DCIS as cancer and recommend removal or destruction of the abnormal tissue.

However, not all DCIS will progress to invasive cancer. Some DCIS remains confined to the duct for years or may never progress at all. This uncertainty is one reason why treatment decisions for DCIS can feel more complex than for invasive cancer — the risk is real but not inevitable.

How DCIS is found and diagnosed

DCIS is usually discovered on a mammogram, often during routine screening. The mammogram shows microcalcifications — tiny deposits of calcium in the breast tissue — that may suggest abnormal cells. A biopsy is then performed to confirm the diagnosis. During a biopsy, a small sample of tissue is removed and examined under a microscope by a pathologist.

The pathologist looks at the cells to determine whether they are DCIS and, if so, what grade they are. DCIS is graded as low, intermediate, or high based on how abnormal the cells appear. Higher-grade DCIS tends to grow faster and carries a higher risk of progressing to invasive cancer. This grade helps guide treatment decisions.

Sometimes DCIS is found by accident when a biopsy is done for another reason, or when tissue is removed during surgery for a benign breast condition. In other cases, a woman may feel a lump or notice discharge from the nipple, though DCIS often causes no symptoms at all.

Treatment options for DCIS

Surgery is the standard treatment for DCIS. The most common approach is lumpectomy — removal of the DCIS and a margin of normal tissue around it. The goal is to remove all the abnormal cells while preserving as much of the breast as possible. After lumpectomy, radiation therapy is often recommended to reduce the risk of recurrence in the same breast.

Some people choose mastectomy — removal of the entire breast — instead of lumpectomy. This is an option, though it is not always necessary for DCIS. Mastectomy may be recommended if the DCIS is large, in multiple locations within the breast, or if the person has other risk factors for breast cancer.

In certain cases, doctors may recommend hormone therapy with tamoxifen or an aromatase inhibitor after surgery. These medications reduce the risk of developing new breast cancer in either breast, particularly in people with hormone receptor-positive DCIS. The decision to use hormone therapy depends on the grade of the DCIS, the person's age, and other individual factors.

What happens after DCIS treatment

After surgery and any radiation or hormone therapy, the focus shifts to monitoring. Regular mammograms are essential — typically every 6 to 12 months for the first few years, then annually. These mammograms watch for recurrence of DCIS in the same breast or new cancer in the other breast.

Clinical breast exams by a doctor are also part of follow-up care. During these exams, the doctor feels the breast tissue for any lumps or changes. Some doctors recommend monthly self-exams as well, though the benefit of self-exams compared to clinical exams is debated.

The risk of recurrence varies. Studies show that roughly 10 to 15 percent of people treated for DCIS will have a recurrence within 10 years. Most recurrences are caught early on mammography, before they become invasive. If recurrence does occur, treatment options are discussed based on the specifics of the new finding.

Living with a DCIS diagnosis

A DCIS diagnosis can feel frightening because it carries the word "cancer," but the reality is that DCIS is highly treatable and the long-term outlook is very good. Many people live their entire lives after DCIS treatment without ever developing invasive breast cancer.

It is normal to have questions and concerns about the diagnosis and treatment. Talking with your doctor about your individual risk factors, the grade of your DCIS, and the pros and cons of different treatment options can help you feel more confident in your decisions. Some people find it helpful to seek a second opinion, particularly if they are considering mastectomy versus lumpectomy.

Support groups — whether in person or online — can also help. Connecting with others who have been diagnosed with DCIS can provide perspective and practical advice about managing follow-up care and the emotional aspects of the diagnosis.

Frequently Asked Questions

Will DCIS definitely turn into invasive cancer?

No. Studies show that without treatment, about 20 to 30 percent of DCIS will progress to invasive cancer within 10 years. That means 70 to 80 percent will not progress. With treatment, the risk of progression is much lower. However, because the risk exists, DCIS is treated as cancer.

Do I need chemotherapy for DCIS?

Chemotherapy is rarely used for DCIS because the cancer has not spread beyond the duct. Surgery, with or without radiation and hormone therapy, is the standard approach. Your doctor will discuss whether hormone therapy is recommended based on your specific situation.

Can DCIS come back after treatment?

Yes, recurrence can happen. About 10 to 15 percent of people treated for DCIS experience recurrence within 10 years. This is why regular mammograms and clinical exams are important — they catch recurrence early, usually before it becomes invasive cancer.

Is DCIS in one breast a sign I will get cancer in the other breast?

DCIS in one breast does not mean the other breast will develop cancer, but it does indicate that you have breast tissue that is prone to abnormal changes. This is why both breasts are monitored closely with mammograms after treatment. Some people choose preventive hormone therapy to reduce the risk of new cancer in either breast.

What does it mean if my DCIS is high grade?

High-grade DCIS means the abnormal cells look more different from normal cells and tend to grow faster. High-grade DCIS carries a higher risk of progressing to invasive cancer compared to low-grade DCIS. This may influence your treatment decisions — for example, radiation after lumpectomy is often recommended for high-grade DCIS.